Pharmaceutical Commercialization

OUR SERVICES

BlueRidge Life Sciences Pharmaceutical Commercialization experts collaborate with clients to define and quantify the value of their therapies for payers, patients, providers and society through innovative strategies and robust evidence generation.

    • Evidence landscape

    • Evidence gap assessment

    • Evidence generation plan

    • Targeted and Systematic Literature Reviews

    • Meta-analyses

    • Network Meta-Analysis

    • Indirect treatment comparison

    • Cost of illness

    • Healthcare resource use

    • Treatment patterns and outcomes

    • Post-hoc analyses

    • Expert elicitation studies

    • Budget impact

    • Cost consequence

    • Cost-effectiveness/utility

    • Value demonstration

    • Early models

    • Support with HTA and ICER

    • Dossier development

    • Dissemination

WHAT WE DO

Our Pharmaceutical Commercialization services are designed to support clients across all clinical development stages